NO993171L - Substituerte propionylderivater - Google Patents

Substituerte propionylderivater

Info

Publication number
NO993171L
NO993171L NO993171A NO993171A NO993171L NO 993171 L NO993171 L NO 993171L NO 993171 A NO993171 A NO 993171A NO 993171 A NO993171 A NO 993171A NO 993171 L NO993171 L NO 993171L
Authority
NO
Norway
Prior art keywords
group
single bond
divalent
bond
esterified
Prior art date
Application number
NO993171A
Other languages
English (en)
Other versions
NO993171D0 (no
Inventor
Hiroyuki Usui
Katsuji Kagechika
Hajime Nagashima
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of NO993171D0 publication Critical patent/NO993171D0/no
Publication of NO993171L publication Critical patent/NO993171L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/51—Y being a hydrogen or a carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/708—Ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/54—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/66—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/12—1,4-Dioxanes; Hydrogenated 1,4-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Foreliggende oppfinnelse angår en forbindelse representert ved den følgende formel (1):. [hvor, Xrepresenterer en karboksylgruppe som kan være forestret eller lignende gruppe; Yrepresenterer en enkeltbinding, -O- eller -N(R)-; minst én av A, A2 og Aer en gruppe representert ved den følgende formel (2):{hvor,.Rrepresenterer en divalent C.,hydrokarbongruppe, R3 representerer en enkeltbinding eller en divalent C,.,hydrokarbongruppe, a' og a2 individuelt representerer en enkeltbinding, -S-, -SO-, -S0-, -S0NH-, -O-, -N(R)-, -CO(R)-, -C(=0)- eller -Si(R')(R)- og -► betyr binding med Q\ Qeller, de gjenværende én eller to av A, Aog A3 er like eller forskjellige og representerer hver uavhengig en gruppe representert ved den følgende formel (3):{hvor, R" og Rindividuelt representerer en enkeltbinding eller en divalent C,.,hydrokarbongruppe, aog aindividuelt representerer en enkeltbinding, -S-, -SO-, -S0-, -S0NH-, -O-, -N(R)-, -CON(R)-, -C(=0)- eller -SI(R)(R)- og betyr binding med Q\ Qeller Q},;. minst én av Q, Qog Qrepresenterer en cyklisk hydrokarbongruppe eller heterocyklisk gruppe og de gjenværende én eller to av Q\ Qog Qindividuelt representerer et hydrogenatom, en karboksylgruppe som kan være forestret, en hydrokarbongruppe eller en heterocyklisk gruppe] eller et salt derav; og et farmasøytisk preparat omfattende disse som aktiv bestanddel. Forbindelsene har sterk skvalen-syntetase-hemmende virkning og er derfor nyttige som farmasøytiske preparater for behandling/forebyggelse av hyperkolesterolemi, hyperlipemi eller arteriosklerose.
NO993171A 1996-12-27 1999-06-25 Substituerte propionylderivater NO993171L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP35067396 1996-12-27
PCT/JP1997/004879 WO1998029380A1 (fr) 1996-12-27 1997-12-26 Derives de propionyle substitues

Publications (2)

Publication Number Publication Date
NO993171D0 NO993171D0 (no) 1999-06-25
NO993171L true NO993171L (no) 1999-08-25

Family

ID=18412084

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993171A NO993171L (no) 1996-12-27 1999-06-25 Substituerte propionylderivater

Country Status (7)

Country Link
EP (1) EP0949238A1 (no)
AU (1) AU5341198A (no)
BR (1) BR9714087A (no)
CA (1) CA2275603A1 (no)
ID (1) ID22281A (no)
NO (1) NO993171L (no)
WO (1) WO1998029380A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR029304A1 (es) * 1998-06-26 2003-06-25 Daiichi Seiyaku Co DERIVADOS DE PROPIONILO SUSTITUIDOS, PRODUCTO FARMACEUTICO, USO PARA LA FABRICACION DE UNA COMPOSICION FARMACEUTICA PARA LA PREVENCION Y/O TRATAMIENTO DE HIPERCOLESTEROLEMIA, HIPERLIPEMIA O ARTERIOESCLEROSIS, COMPOSICIoN FARMACÉUTICA Y COMPUESTOS INTERMEDIARIOS
CO5170498A1 (es) * 1999-05-28 2002-06-27 Abbott Lab Biaril sulfonamidas son utiles como inhibidores de proliferacion celular
US6521658B1 (en) 1999-05-28 2003-02-18 Abbott Laboratories Cell proliferation inhibitors
US6797820B2 (en) 1999-12-17 2004-09-28 Vicuron Pharmaceuticals Inc. Succinate compounds, compositions and methods of use and preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023342A (en) * 1988-05-26 1991-06-11 Massachusetts Institute Of Technology Cyclic sulfate compounds
JP2753871B2 (ja) * 1989-10-19 1998-05-20 三菱化学株式会社 有機高分子液晶薄膜及び情報記録方法
JPH03266819A (ja) * 1990-03-16 1991-11-27 Fuji Electric Co Ltd 非線形光学材料
CA2115183A1 (en) * 1993-02-12 1994-08-13 Takashi Nomoto Substituted amic acid derivatives

Also Published As

Publication number Publication date
NO993171D0 (no) 1999-06-25
WO1998029380A1 (fr) 1998-07-09
ID22281A (id) 1999-09-30
CA2275603A1 (en) 1998-07-09
AU5341198A (en) 1998-07-31
EP0949238A1 (en) 1999-10-13
BR9714087A (pt) 2000-05-09

Similar Documents

Publication Publication Date Title
ATE227293T1 (de) 2,3-disubstituierte-(5,6)-heteroarylkondensiert - pyrimidin-4-one
ATE273273T1 (de) Phenylalaninderivate als inhibitoren von alpha4 integrinen
AU1463195A (en) Substituted aromatic compounds as c.amp phosphodiesterase- and tnf-inhibitors
NO20052802L (no) Pyrrolopyrimidinderivativer
NO993868L (no) 3-piperidyl-4-oksokinazolinderivater og farmasöytiske preparater omfattende samme
PT1158973E (pt) Utilizacao de derivados de sulfamato para o tratamento dos disturbios do controlo de impulsos
LU91076I9 (en) 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
CA2075173A1 (en) Compounds and methods for inhibition of hiv and related viruses
CA2301742A1 (en) 2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2
WO1996016079A3 (en) Alpha-ketoamide derivatives as cathepsin l inhibitor
CA2233315A1 (en) Pharmaceutical compositions containing hydroximic acid derivatives
CA2238845A1 (fr) Nouveaux derives de 2,3,5-trimethyl-4-hydroxy anilides, leur preparation et leur application en therapeutique
DE69635857D1 (de) Pyrrolderivate und medizinische zubereitung.
NO984740L (no) Isatinderivater som acetylcholinesteraseinhibitorer og analgetiske midler
NO993171L (no) Substituerte propionylderivater
CA2150546A1 (en) Agent for inhibiting production of interleukin-8
AU1398797A (en) 3-(bis-substituted-phenylmethylene)oxindole derivatives
NO980788L (no) Immunosuppressant
DK1025101T3 (da) Naphtho-imidazo[1,2-a]pyridinderivater, deres fremstilling og deres anvendelse ved behandlingen af sygdomme i centralnervesystemet
WO1998029407A3 (en) N-(pyridinylamino)isoindolines for treating alzheimer's and depression
JPS5643264A (en) 1-oxoisoindoline derivative and preventive for plant disease containing the same as the effective component
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
WO1999065474A3 (en) Compositions for treating cartilage disease comprising certain sulfur-containing heterocyclic compounds
WO2000008006A3 (en) Piperidine and piperazine derivatives, process for their preparation and pharmaceutical compounds containing them
NO943472D0 (no) Cykloheksan-derivat, farmakologisk preparat omfattende dette, og fremgangsmåte for forebygging/behandling av sykdommer ved anvendelse av nevnte cykloheksanderivat

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application